Firefly Neuroscience, Inc. AIFF 深 沪
等待开盘 08-19 09:30:00 美东时间
1.09
-0.040
-3.54%
华盛通- 最 高1.1396
- 今 开1.10
- 成交量 5.49万股
- 最 低 1.08
- 昨 收 1.13
- 总市值 1710.24万
- 52周最高 3.1499
- 市盈率 静 --
- 换手率 0.35%
- 52周最低 0.6175
- 委 比 76.65%
- 总股本 1569.03万
- 历史最高 180.00
- 量 比 0.51
- 振 幅 5.27%
- 历史最低 0.6175
- 每 手 1
- 风险率 0.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Firefly Neuroscience And Next Health Partner To Launch Precision Cognitive Health Platform Integrating Firefly’s AI-Powered, FDA-Cleared EEG/ERP Brain Biomarker Technology With Personalized Cognitive Peptide Protocols
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their potential neuroprotective and cognitive-supportive properties – – Collaboration rep...
07-28 19:52
Firefly Neuroscience Announces Identification Of Electrophysiological Biomarker For Post-Traumatic Stress Disorder Using Brain Scans Collected On FDA-510(k)-Cleared Evoke System
– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War –KENMORE, N.Y, June 02, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company")
06-02 19:41
Firefly Neuroscience Announces Over 200K EEG/ERP Scans
Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and
04-13 19:49
Firefly Neuroscience Q4 EPS $(0.15) Up From $(0.45) YoY, Sales $412.000K Up From $63.000K YoY
Firefly Neuroscience (NASDAQ:AIFF) reported quarterly losses of $(0.15) per share. This is a 66.67 percent increase over losses of $(0.45) per share from the same period last year. The company reported $412.000 thousand
04-01 06:47
Firefly Neuroscience Partners With Department Of Defense To Support Assessment, Treatment Of Active-Duty U.S. Service Members And Veterans Suffering From PTSD And/Or Traumatic Brain Injury
Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service MembersPartnership Represents a Significant Expansion of Company's Commercial
03-26 19:49
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Fr...
03-21 05:05
Why Firefly Neuroscience Stock Is Soaring Today
Firefly Neuroscience shares are trading higher Friday after it advanced research using its Evoke System to help distinguish ADHD subtypes.
03-14 03:15
Firefly Neuroscience Sells 1.5M Units At $1.50/Unit To Raise $2.25M; Gives Option For Investors To Buy Up To 13.5M Units And Expand Deal To $20.25M
Entry into a Material Definitive Agreement. On March 8, 2026, Firefly Neuroscience, Inc., a Delaware corporation (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with
03-13 05:10
What's Going On With Firefly Neuroscience Stock On Friday?
Firefly Neuroscience stock climbs after a major expansion in brain scan partnerships and rapid growth in its EEG data network.
03-07 01:07
What's Driving the Market Sentiment Around Firefly Neuroscience Inc?
Firefly Neuroscience Inc's (NYSE:AIFF) short interest as a percent of float has...
03-07 00:00
